ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants.
ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause 
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Oliver Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa
Advisory Committee: J. Apperley, S. Branford, C. Gambacorti-Passerini, F. Guilhot, R. Hehlmann, P. Laneuville, F-X. Mahon, D. Perrotti, G. Saglio, C. Schiffer, S. Soverini, P. Valent, R. Van Etten
The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants. There are also scientific workshops to discuss the latest technologies of value in CML research, and clinical symposia with focus on topics of interest to the CML community. There are special lectures on topics of general interest to the CML community from lead experts in their field. The program is designed to encourage discussion and collaboration among participants, presenters and attendees.
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.
 
Posters and Brief Oral Communications:
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
Call for abstracts: deadline May 22nd, 2025
The meeting will be of interest to:
- Junior and senior biologists and clinicians (MD, PhD, MD-PhD)
- Residents and biologists still in-training
- Physicians and other healthcare providers managing patients with CML
- Researchers with interest in hematologic malignancies and myeloproliferative neoplasms in general, and CML in particular
The program will include:
- Plenary Sessions
- Workshops for Non-Clinical Scientists
- Panel Discussions
- Simultaneous Meet the Expert Sessions
- Mentored Poster Walks
- Controversial Debates
- Ample Time for in-depth discussion
For questions please email: [email protected]

External Events

Mar 26
25
26
27
Apr 26
24
29
Sept 26
21
March 25th 2026
Integrated Diagnostics - Haematology and Histop...
The course is suitable for haematology, histopathology consultants and trainees alike along with biomedical scientist...
Details
March 26th 2026
Laboratory Aspects of Haemoglobinopathy Diagnos...
Suitable for Consultants and other Career Grade post holders in haematology, trainees in haematology and biomedical s...
Details
March 26th 2026
ESH 8th Translational Research Conference: Mult...
An outstanding faculty of myeloma experts will present the most recent advances and perspectives in the field of plas...
Details
March 27th 2026
One-Day Intensive Morphology Update for Biomedi...
Suitable for experienced Biomedical Scientists and Haematology Trainees in the first two years of their training.
Details
April 24th 2026
ESH 11th Translational Research Conference: Mye...
ESH Translational Research Conferences propose programmes of leading-edge basic and clinical science, as well as oppo...
Details
April 29th 2026
3rd GVHD Academy
This virtual evening event will provide an update on a variety of GVHD topics: prevention and treatment, lung GVHD, q...
Details
September 21st 2026
Haematology in Obstetrics course 2026
The Haematology in Obstetrics course aims to develop an understanding of the physiology and pathology of obstetric ha...
Location: St Edmund Hall, Oxford University
Details